Rapport Therapeutics (RAPP) IPO deck
Rapport Therapeutics is a clinical-stage biopharmaceutical company developing precision small molecule therapies to transform CNS disorder treatments.
![](/content/images/size/w1304/2024/06/RAPP_01-1.png)
Rapport Therapeutics is a clinical-stage biopharmaceutical company developing precision small molecule therapies to transform CNS disorder treatments.